Tom Pelckmans

vader, echtgenoot , vriend, familieman. Man met een eigen kijk op de wereld. #rsca #foofighters #belgium

[Tonix Pharmaceuticals @TonixPharma]

Today we announced the first patient has been enrolled in the Phase 2 HORIZON study of TNX-102 SL for the treatment of #majordepressivedisorder. Learn more: https://t.co/ocXQJDqv7e
#MDD #Tonix

[Tom Pelckmans @tompelckmans]

@tenet_research @Arhdan9

[Crwe World @CrweWorld]

Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD) $TNXP, #TonixPharmaceuticals, #TonixPharma, #Tonix https://t.co/UbKI2TJh9i

[ZoZoTrader 🇺🇸🇨🇦📈📉🚴‍♂️ @ZoZoStockwatch]

$TNXP - Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD) - https://t.co/mIvxn0qlOn

[Boominance @boominance]

Tonix Pharma $TNXP — Raymond James: Strong Buy ‖ TP $26
Intel $INTC — Goldman Sachs: Neutral ‖ TP $150
Castle Biosciences $CSTL — Roth Capital: Buy ‖ TP $40
Arrow Financial $AROW — KBW: Market Perform ‖ TP $42 #stockalerts #TradingTips

[TENET RESEARCH @tenet_research]

$TNXP | Raymond James Initiates Tonix Pharma at Strong Buy with $26.00 PT on TONMYA Commercial Launch Inflection

Raymond James starts bullish as TONMYA access expansion and early commercial traction drive potential upside re-rating.

@ripster47 | @TENETTRADEGROUP | @TenetCharts

[Tom Pelckmans @tompelckmans]

@Mustafa4263081 And now $TNXP is $12.50. Not bad 🚀

[Tom Pelckmans @tompelckmans]

#TNXP

[Hottest Stocks Now @HottestStockNow]

Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA $TNXP, #TonixPharmaceuticals, #TonixPharma, #Tonix https://t.co/5AWsvMBLi1

[Tom Pelckmans @tompelckmans]

#TNXP

[Tonix Pharmaceuticals @TonixPharma]

Complex conditions like fibromyalgia don't always follow a linear path, and responsive care can't be built on that premise. Today in @RealClearHealth, I outline how policy and research can accelerate a shift in better treating invisible conditions and chronic illnesses:

https://t.co/krntEoM7jA

[Tom Pelckmans @tompelckmans]

#TNXP

[Tonix Pharmaceuticals @TonixPharma]

Tonix published Phase 1 clinical data for TNX-1500 in the peer-reviewed Journal of Clinical Immunology. Read more about our Phase 2 ready, investigational, anti-CD40L monoclonal antibody: https://t.co/bH6j5DnHvd

#Tonix #Immunology #KidneyTransplant

[Arh Dan @Arhdan9]

@davidji84082521 @SethLederman $TNXP
Here you go. Note after a huge spike on the week of May 1, this week's normally fall back a bit, but delta, ie, refill numbers increase in number than I expected.
all in all, a healthy grow intact.

[Tom Pelckmans @tompelckmans]

@rsca34sporting1 En da’s goe?

[Tom Pelckmans @tompelckmans]

#TNXP

[Tonix Pharmaceuticals @TonixPharma]

Thanks to @Lymealliance for hosting a symposium focused on the latest advances in Lyme last week! We appreciated the opportunity to sponsor the event and present on our investigational monoclonal antibody, TNX-4800.

#LymeDisease #LymeDiseaseAwarenessMonth

[DuckMan @DuckStockMan]

Another major partnership for $RZLV 🚀

Rezolve AI just announced a multi-million dollar strategic partnership with Enhanced Group (NYSE: ENHA) to power AI-native fan engagement, digital experiences, and future AI-driven healthcare features across the Enhanced ecosystem.

Rezolve AI will power:
• AI-enabled fan engagement
• Mobile-first digital experience for Enhanced Games Las Vegas
• Conversational AI concierge
• Future tele-health & AI Doctor capabilities
• AI-driven personalization ecosystem

This comes after partnerships with Microsoft, Google, TCS, Tether and others.

$RZLV is rapidly expanding beyond retail into sports, healthcare-adjacent platforms, entertainment, payments, and agentic commerce. 👀🔥

[Arh Dan @Arhdan9]

$TNXP
Reacceleration indeed, the numbers don't lie.
This is the backdrop of our investment sanity which be #10bagger as more payers onboard in near future.
Also institutions and hedge have loaded up.

[Tom Pelckmans @tompelckmans]

#TNXP

[Tonix Pharmaceuticals @TonixPharma]

We look forward to our poster presentation at @ISPOR2026 on a retrospective U.S. real-world claims analysis characterizing patients with #fibromyalgia. Learn more, and see you there: https://t.co/Mo5lQXmIBO
#TNXP #Biotech #Fibromyalgia

[Tonix Pharmaceuticals @TonixPharma]

We look forward to our poster presentation at @ISPOR2026 on a retrospective U.S. real-world claims analysis characterizing patients with #fibromyalgia. Learn more, and see you there: https://t.co/Mo5lQXmIBO
#TNXP #Biotech #Fibromyalgia

[Rezolve Ai @RezolveAi]

Rezolve Ai is pleased to announce a global strategic partnership designed to accelerate the worldwide rollout of agentic commerce.

Under the agreement, Tata Consultancy Services will resell Rezolve’s AI-powered commerce platform to enterprise clients globally, giving Rezolve access to one of the broadest client relationships, delivery capabilities and digital transformation footprints in the world.

🔗Press release: https://t.co/0YeqJlRWtv

#RezolveAi #StrategicPartnership #Tata #AgenticCommerce $RZLV

[Lycanbull @Lycanbull]

Tonix Pharmaceuticals Secures Commercial Payer Coverage for TONMYA®, Providing Access for ~35 Million U.S. Patients $TNXP
https://t.co/oKb3gX3KuD

[Tom Pelckmans @tompelckmans]

#TNXP

[Tonix Pharmaceuticals @TonixPharma]

Today begins #FibromyalgiaAwarenessMonth💜 10 million+ adults in the U.S. live with #fibromyalgia, which causes all-encompassing impacts to their daily life. Yet they can often feel invisible or misunderstood.

#Tonix is committed to advancing scientific innovation and raising awareness for fibromyalgia to support patients, their loved ones, and their care partners.

#FibromyalgiaAwareness #ChronicPain #PatientsFirst

[Tom Pelckmans @tompelckmans]

#TNXP 🚀

[Tonix Pharmaceuticals @TonixPharma]

Today we announced the presentation of Ph. 1 data and plans for an adaptive Ph. 2 field study of TNX-4800, our investigational #monoclonalantibody for the prevention of #Lymedisease in the U.S., at @JohnsHopkinsSPH Ticks and Tickborne Diseases Symposium. https://t.co/QIkxWpTOtb

#Tonix